StackTerminal.Health

TUDCA (Tauroursodeoxycholic Acid)

TUDCA is a taurine-conjugated bile acid and chemical chaperone that inhibits ER stress, supports mitochondrial integrity, and exerts hepatoprotective effects; human RCTs demonstrate liver enzyme normalization in cirrhosis and improvements in hepatic insulin sensitivity.

liverhepatoprotectivemetabolicmitochondrialgut-healthneuroprotective
Dosing model
FLATFixed dose (no body-weight scaling).
Min dose
250 mg
Max dose
750 mg
Rounding
250 mg

Stacks containing TUDCA (Tauroursodeoxycholic Acid)

Public community stacks that include this ingredient.

Explore all stacks →
No public stacks include this ingredient yet.
Evidence
2 records
Liver enzymes and biochemical markers in liver cirrhosis
Adults with liver cirrhosisdouble-blind RCT
Low

A double-blind RCT (n=18, 750 mg/day, 6 months) found TUDCA significantly reduced serum ALT, AST, and ALP versus baseline, outperforming UDCA on biochemical normalization; both groups showed increased albumin. TUDCA was concluded to be safe and more effective than UDCA for biochemical improvement.

Dose: 750 mg Duration: 6 months
Small trial (n=18); findings are preliminary. Larger trials needed to confirm efficacy.
Hepatic and muscle insulin sensitivity
Obese men and womenRCT
Low

A placebo-controlled RCT (n=20, 1750 mg/day, 4 weeks) found TUDCA improved both hepatic and muscle insulin sensitivity by approximately 30% versus placebo; adipose tissue insulin sensitivity was unchanged; ER stress markers did not change, suggesting an alternative mechanism beyond classical chaperone activity.

Dose: 500 mg Duration: 4 weeks
Dose of 1750 mg/day used in this study is higher than typical OTC supplementation (250–750 mg/day).
Forms